1] Department of Ophthalmology, Moorfields Eye Hospital, London, UK [2] UCL Institute of Ophthalmology, London, UK.
1] Department of Ophthalmology, Moorfields Eye Hospital, London, UK [2] Centre for Population Health Sciences, University of Edinburgh, Edinburgh, UK.
Eye (Lond). 2014 Sep;28(9):1066-79. doi: 10.1038/eye.2014.145. Epub 2014 Jun 27.
Genome-wide association studies (GWAS) use high-throughput genotyping technologies to genotype thousands of single-nucleotide polymorphisms (SNPs) and relate them to the development of clinical and quantitative traits. Their use has been highly successful in the field of ophthalmology, and since the advent of GWAS in 2005, many genes not previously suspected of having a role in disease have been identified and the findings replicated. We conducted an extensive literature review and describe the concept, design, advantages, and limitations of GWAS and provide a detailed description of the applications and discoveries of GWAS in the field of eye disease to date. There have been many novel findings revealing previously unknown biological insights in a diverse range of common ocular conditions. GWAS have been a highly successful modality for investigating the pathogenesis of a wide variety of ophthalmic conditions. The insights gained into the pathogenesis of disease provide not only a better understanding of underlying disease mechanism but also offer a rationale for targeted treatment and preventative strategies. Expansive international collaboration and standardised phenotyping will permit the continued success of this investigative technique.
全基因组关联研究(GWAS)使用高通量基因分型技术对数千个单核苷酸多态性(SNP)进行基因分型,并将其与临床和定量特征的发展联系起来。它们在眼科领域的应用非常成功,自 2005 年 GWAS 问世以来,许多以前被认为与疾病无关的基因已经被确定,并且这些发现已经得到了复制。我们进行了广泛的文献回顾,描述了 GWAS 的概念、设计、优势和局限性,并详细描述了 GWAS 在眼部疾病领域迄今为止的应用和发现。有许多新的发现揭示了在各种常见眼部疾病中以前未知的生物学见解。GWAS 是一种非常成功的研究多种眼科疾病发病机制的方法。对疾病发病机制的深入了解不仅提供了对潜在疾病机制的更好理解,还为有针对性的治疗和预防策略提供了依据。广泛的国际合作和标准化的表型将允许这种研究技术的持续成功。